Security key
92189F692
- Security type / class
- Equity / PHARMACEUTCL ETF
- Total 13F shares
- 6,556,396
- Total 13F value
- $509,704,617
- Share change
- +351,122
- Put/Call ratio
- 13%
- SEC-reported price per share
- $77.74
- Number of holders
- 111
- Value change
- +$29,919,137
- Number of buys
- 52
- Number of sells
- 34
Open additional details 1 more signal available
Report period
Q4 2022
Institutions
111
Top holders
10
PPH full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Broader feeds
Reporting periods
Holder history for CUSIP 92189F692
Recent filing periods:
Ownership snapshot
Top reported holders of PPH - VANECK ETF TRUST - PHARMACEUTCL ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
111
Shares
6,556,396
Rows available
111
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
85
Q4 2022 holders
111
Holder diff
26
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend